Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-08-15
2006-08-15
Turner, Sharon (Department: 1649)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S069100
Reexamination Certificate
active
07090985
ABSTRACT:
The present invention is drawn to methods of characterization of the properties and functions of SV2 proteins. The invention further includes methods of identifying compounds or agents which modulate the activity of SV2 proteins. Included in these methods is the identification of compounds or agents which modulate the binding of levetiracetam SV2 proteins, including SV2A.
REFERENCES:
patent: 2002/0142383 (2002-10-01), Merkulov et al.
patent: 2003/0009024 (2003-01-01), Curtis
Genbank Accession O94841, May 1, 1999, KIAA0736 human SV2 in DNA Res., 5:277-286, 1998, 100% identical to SEQ ID No. 2.
Lynch et al., PNAS, 101(26):9861-66, Jun. 29, 2004.
Differding et al., (EP01/01992) published as WO01/62726, Aug. 30, 2001.
Choh et al., PNAS, 77(6):3211-14, 1980.
Miyata et al., Br. J. of Haematology, 88:156-65, 1994.
Skolnick et al., TIBTECH., 18(1):34-39, 2000.
Janz, R et al. SVOP, an evolutionarily conserved synaptic vesicle protein, suggests novel transport functions of synaptic vesicles. J Neurosci. 1998; 18(22):9269-9281.
Janz, R et al. SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release. Neuron. 1999; 24(4):1003-1016.
Janz, R. Knockout mice and SV2 synaptic-vesicle proteins. University of Texas Health Science Center at Houston Neuroscience Research Center Newsletter. 2001; 7(3):1,4-5.
Margineanu, DG et al. Levetiracetam: Mehanisms of action.In:Antiepileptic Drugs, 5ht Editiion. Levy,RH et al.eds. 2002; Lippincott Williams & Wilkins, Philadelphia, PA. pp. 419-427.
Noyer, M et al. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes. Eur J Pharmacol. 1995; 286(2)137-146.
Pyle, RA et al. Phosphorylation of synaptic vesicle protein 2 modulates binding to synaptotagmin. J Biol Chem. 2000; 275(22):17195-17200.
Schivell, AE et al. Isoform-specific, calcium-regulated interaction of synaptic vesicle proteins SV2 and synaptotagmin. J Biol Chem. 1996; 271(44):27770-27775.
Son, Y-J et al. The synaptic vesicle protein SV2 is complexed with an alpha5- containing laminin on the nerve terminal surface. J Biol Chem. 2000; 275(1):451-460.
Xu, T et al. SV2 modulates the size of the readily releasable pool of secretory vesicles. Nat Cell Biol. 2001; 3(8):691-698.
Bajjalieh SM, et al. SV2, a brain synaptic vesicle protein homologous to bacterial transporters. Science 1992; 257(5074):1271-1273.
Bajjalieh SM, et al. Brain contains two forms of synaptic vesicle protein 2. Proc Natl Acad Sci (USA). 1993; 90(6):2150-2154.
Bajjalieh SM, et al. Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci. 1994 ; 14(9):5223-5235.
Buckley, K et al. Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 1985; 100(4):1284-1294.
Crowder, KM et al. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A). Proc Natl Acad Sci (USA). 1999; 96(26):15268-15273.
Feany, MB et al. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter. Cell. 1992; 70(5):861-867.
Hayashi, M et al. Syntaptic vesicle protein SV2B, but not SV2A, is predominantly expressed and associated with microvesicles in rat pinealocytes. Adv Exp Med Biol. 1999; 460:91-93.
Fuks Bruno
Lynch Berkley
Nocka Karl
Morgan & Lewis & Bockius, LLP
Turner Sharon
UCB S.A.
LandOfFree
Methods for the identification of agents for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the identification of agents for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the identification of agents for the treatment... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3677426